Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.





Inbox: RCB kürzt Wolford-Kursziel


Wolford
Akt. Indikation:  3.86 / 4.06
Uhrzeit:  11:01:31
Veränderung zu letztem SK:  1.02%
Letzter SK:  3.92 ( -0.51%)

21.08.2017

Zugemailt von / gefunden bei: RCB (BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

Wolford confirmed at REDUCE, TP EUR 16.0 - FY 16/17 in line with guidance, major change looms

- We confirm our REDUCE call while we decrease our TP to EUR 16.0 from EUR 19.0 as we lower our operational forecasts
- While the FY 16/17 operating loss of EUR 15.7 mn fell within the guided range the company adjusted FY 15/16 figures, decreasing the operating result from a profit of EUR 1.6 mn to a loss of EUR 2.9 mn
- Despite a decent start of 17/18e year the company expects only a modest yoy revenue growth and an operating loss, while a return to positive operating earnings is expected only by 18/19e
- Mr. Ashish Sensarma, CEO since January 2015, has left the management board on August 1 and Mr. Axel Dreher (previously CFO), assumed his responsibilities
- The core shareholders are in the midst of a process for the selection of interested parties

PLEASE USE THIS LINK TO DOWNLOAD THE DOCUMENT

Following the release of corporate news on August 8, 2017 including the results for 2016/17 we decrease our TP to EUR 16.0 from EUR 19.0 while confirming our REDUCE recommendation for Wolford. While the FY 16/17 operating loss of EUR 15.7 mn fell within the guided range burdened by revaluations and restructuring costs, the company adjusted the FY 15/16 figure, decreasing the operating result from a profit of EUR 1.6 mn to a loss of EUR 2.9 mn. As the main shareholders seek an exit in an open process and a potential equity financing looms we remain cautious with regard to prospects for minority investors. We are not surprised by the changes at the top given the challenges the company has been facing with the implementation of the restructuring plan and a planned sale by the main shareholder group.
 
FY 16/17 results: The top line shrank by 5.0% yoy to EUR 154.3 mn, while the operating loss worsened to EUR 15.7 mn (within the guided EUR 15-19 mn range) from EUR 2.9 mn (adjusted) in FY 15/16. The bottom line loss amounted to EUR 17.9 mn vs a loss of EUR 10.7 mn (adjusted) in FY 15/16. The company will release full annual consolidated statements on August 24.
 
Changes at the helm: Mr. Ashish Sensarma, CEO since January 2015, has left the management board on August 1 and Mr. Axel Dreher (previously CFO), assumed his responsibilities (strategy, marketing, production). The head of the finance department, Ms. Brigitte Kurz took over the role of CFO as well as the responsibility for HR, IT, legal and investor relations.
 
Outlook: On June 9 Wolford communicated that the main shareholder group (WMP Familien-Privatstiftung, Sesam Privatstiftung and its subsidiary the "M. Erthal & Co." Beteiligungsgesellschaft m.b.H.), as well as related parties announced the intention to sell their stake (ca 65%). The shareholders have hired a financial advisor and started a process for the selection of interested parties. The purchase of the majority stake by a future core shareholder shall be combined with an equity financing transaction the size of which has not yet been determined. On July 11, Wolford announced that it has achieved an extension of its credit lines until June 30, 2018 and secured a bridge financing of up to EUR 10 mn for seasonal liquidity requirements. Thus the company has managed to secure financing for the current financial year. We would expect the company and core shareholders to be focussed on achieving a sale within the next 6 months, otherwise we would expect another extension of financing to be required.
 
Valuation: We have lowered our forecasts for 17/18e-19/20e. We base the valuation on our DCF model and decrease our one-year target price to EUR 16.0 per share which results in a confirmed REDUCE recommendation. Our valuation is based on our fundamental assessment of the company which is on the brink of a major shareholder change which could present various scenarios for minority investors.
       

Company im Artikel

Wolford

Für Zusatzliquidität im Orderbuch der Wolford-Aktien sorgen die Raiffeisen Centrobank AG als Specialist sowie die Market Maker Hauck & Aufhäuser und Oddo Seydler Bank AG, Klick auf Institut/Bank öffnet Übersicht.



Wolford (Fotocredit: Michael J. Plos)



Aktien auf dem Radar:Addiko Bank, Immofinanz, Marinomed Biotech, Flughafen Wien, Warimpex, EuroTeleSites AG, ATX Prime, ams-Osram, AT&S, Palfinger, RBI, Strabag, Pierer Mobility, UBM, CA Immo, Frequentis, Lenzing, SW Umwelttechnik, Oberbank AG Stamm, Wolford, Agrana, Amag, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger.

(BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

Random Partner #goboersewien

Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/goboersewien


Meistgelesen
>> mehr





PIR-Zeichnungsprodukte
AT0000A2C5J0
AT0000A2U2W8
AT0000A2QS86
Newsflow
>> mehr

Börse Social Club Board
>> mehr
    wikifolio-Trades Austro-Aktien 10-11: Österreichische Post(1)
    Star der Stunde: Agrana 1.87%, Rutsch der Stunde: Andritz -4.34%
    wikifolio-Trades Austro-Aktien 9-10: Kontron(2), Andritz(1), Uniqa(1)
    Star der Stunde: Pierer Mobility 1.69%, Rutsch der Stunde: Warimpex -3.6%
    BSN MA-Event Symrise
    BSN Vola-Event Infineon
    #gabb #1587

    Featured Partner Video

    Börsenradio Live-Blick, Mo. 8.4.24: DAX fester in die neue Woche, Bullenpower bei Zalando und Gold, FACC holt alten Bekannten

    Christian Drastil mit dem Live-Blick aus dem Studio des Börsenradio-Partners audio-cd.at in Wien wieder intraday mit Kurslisten, Statistiken und News aus Frankfurt und Wien. Es ist der Podcast, der...

    Books josefchladek.com

    Martin Frey & Philipp Graf
    Spurensuche 2023
    2023
    Self published

    Stefania Rössl & Massimo Sordi (eds.)
    Index Naturae
    2023
    Skinnerboox

    Kurama
    erotiCANA
    2023
    in)(between gallery

    Carlos Alba
    I’ll Bet the Devil My Head
    2023
    Void

    Andreas H. Bitesnich
    India
    2019
    teNeues Verlag GmbH

    Inbox: RCB kürzt Wolford-Kursziel


    21.08.2017, 4720 Zeichen

    21.08.2017

    Zugemailt von / gefunden bei: RCB (BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

    Wolford confirmed at REDUCE, TP EUR 16.0 - FY 16/17 in line with guidance, major change looms

    - We confirm our REDUCE call while we decrease our TP to EUR 16.0 from EUR 19.0 as we lower our operational forecasts
    - While the FY 16/17 operating loss of EUR 15.7 mn fell within the guided range the company adjusted FY 15/16 figures, decreasing the operating result from a profit of EUR 1.6 mn to a loss of EUR 2.9 mn
    - Despite a decent start of 17/18e year the company expects only a modest yoy revenue growth and an operating loss, while a return to positive operating earnings is expected only by 18/19e
    - Mr. Ashish Sensarma, CEO since January 2015, has left the management board on August 1 and Mr. Axel Dreher (previously CFO), assumed his responsibilities
    - The core shareholders are in the midst of a process for the selection of interested parties

    PLEASE USE THIS LINK TO DOWNLOAD THE DOCUMENT

    Following the release of corporate news on August 8, 2017 including the results for 2016/17 we decrease our TP to EUR 16.0 from EUR 19.0 while confirming our REDUCE recommendation for Wolford. While the FY 16/17 operating loss of EUR 15.7 mn fell within the guided range burdened by revaluations and restructuring costs, the company adjusted the FY 15/16 figure, decreasing the operating result from a profit of EUR 1.6 mn to a loss of EUR 2.9 mn. As the main shareholders seek an exit in an open process and a potential equity financing looms we remain cautious with regard to prospects for minority investors. We are not surprised by the changes at the top given the challenges the company has been facing with the implementation of the restructuring plan and a planned sale by the main shareholder group.
     
    FY 16/17 results: The top line shrank by 5.0% yoy to EUR 154.3 mn, while the operating loss worsened to EUR 15.7 mn (within the guided EUR 15-19 mn range) from EUR 2.9 mn (adjusted) in FY 15/16. The bottom line loss amounted to EUR 17.9 mn vs a loss of EUR 10.7 mn (adjusted) in FY 15/16. The company will release full annual consolidated statements on August 24.
     
    Changes at the helm: Mr. Ashish Sensarma, CEO since January 2015, has left the management board on August 1 and Mr. Axel Dreher (previously CFO), assumed his responsibilities (strategy, marketing, production). The head of the finance department, Ms. Brigitte Kurz took over the role of CFO as well as the responsibility for HR, IT, legal and investor relations.
     
    Outlook: On June 9 Wolford communicated that the main shareholder group (WMP Familien-Privatstiftung, Sesam Privatstiftung and its subsidiary the "M. Erthal & Co." Beteiligungsgesellschaft m.b.H.), as well as related parties announced the intention to sell their stake (ca 65%). The shareholders have hired a financial advisor and started a process for the selection of interested parties. The purchase of the majority stake by a future core shareholder shall be combined with an equity financing transaction the size of which has not yet been determined. On July 11, Wolford announced that it has achieved an extension of its credit lines until June 30, 2018 and secured a bridge financing of up to EUR 10 mn for seasonal liquidity requirements. Thus the company has managed to secure financing for the current financial year. We would expect the company and core shareholders to be focussed on achieving a sale within the next 6 months, otherwise we would expect another extension of financing to be required.
     
    Valuation: We have lowered our forecasts for 17/18e-19/20e. We base the valuation on our DCF model and decrease our one-year target price to EUR 16.0 per share which results in a confirmed REDUCE recommendation. Our valuation is based on our fundamental assessment of the company which is on the brink of a major shareholder change which could present various scenarios for minority investors.
           

    Company im Artikel

    Wolford

    Für Zusatzliquidität im Orderbuch der Wolford-Aktien sorgen die Raiffeisen Centrobank AG als Specialist sowie die Market Maker Hauck & Aufhäuser und Oddo Seydler Bank AG, Klick auf Institut/Bank öffnet Übersicht.



    Wolford (Fotocredit: Michael J. Plos)





    BSN Podcasts
    Christian Drastil: Wiener Börse Plausch

    Börsenradio Live-Blick, Do. 25.4.24: DAX clincht mit 18000, Deutsche Bank, Mercedes, Commerzbank, VIG, Palfinger last 5 im TPT




    Wolford
    Akt. Indikation:  3.86 / 4.06
    Uhrzeit:  11:01:31
    Veränderung zu letztem SK:  1.02%
    Letzter SK:  3.92 ( -0.51%)



     

    Bildnachweis

    1. Wolford (Fotocredit: Michael J. Plos)   >> Öffnen auf photaq.com

    Aktien auf dem Radar:Addiko Bank, Immofinanz, Marinomed Biotech, Flughafen Wien, Warimpex, EuroTeleSites AG, ATX Prime, ams-Osram, AT&S, Palfinger, RBI, Strabag, Pierer Mobility, UBM, CA Immo, Frequentis, Lenzing, SW Umwelttechnik, Oberbank AG Stamm, Wolford, Agrana, Amag, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger.


    Random Partner

    Croma
    Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

    >> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


    Wolford (Fotocredit: Michael J. Plos)


    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Meistgelesen
    >> mehr





    PIR-Zeichnungsprodukte
    AT0000A2C5J0
    AT0000A2U2W8
    AT0000A2QS86
    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      wikifolio-Trades Austro-Aktien 10-11: Österreichische Post(1)
      Star der Stunde: Agrana 1.87%, Rutsch der Stunde: Andritz -4.34%
      wikifolio-Trades Austro-Aktien 9-10: Kontron(2), Andritz(1), Uniqa(1)
      Star der Stunde: Pierer Mobility 1.69%, Rutsch der Stunde: Warimpex -3.6%
      BSN MA-Event Symrise
      BSN Vola-Event Infineon
      #gabb #1587

      Featured Partner Video

      Börsenradio Live-Blick, Mo. 8.4.24: DAX fester in die neue Woche, Bullenpower bei Zalando und Gold, FACC holt alten Bekannten

      Christian Drastil mit dem Live-Blick aus dem Studio des Börsenradio-Partners audio-cd.at in Wien wieder intraday mit Kurslisten, Statistiken und News aus Frankfurt und Wien. Es ist der Podcast, der...

      Books josefchladek.com

      Adrianna Ault
      Levee
      2023
      Void

      Sergio Castañeira
      Limbo
      2023
      ediciones anómalas

      Andreas Gehrke
      Flughafen Berlin-Tegel
      2023
      Drittel Books

      Cristina de Middel
      Gentlemen's Club
      2023
      This Book is True

      Ed van der Elsken
      Liebe in Saint Germain des Pres
      1956
      Rowohlt